LCTX Net Receivables
Lineage Cell Therapeutics, Inc. Common Stock · Net Receivables
LCTX Net Receivables
Latest reported$790.00Kperiod ending
LCTX Quarterly Net Receivables ($0.00 → $790.00K)
Quarterly net receivables
High-resolution chart · PNG
LCTX net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 790,000 | |
| 806,000 | |
| 1,562,000 | |
| 127,000 | |
| 256,000 | |
| 213,000 | |
| 638,000 | |
| 405,000 | |
| 235,000 | |
| 77,000 | |
| 745,000 | |
| 432,000 | |
| 443,000 | |
| 203,000 | |
| 297,000 | |
| 434,000 | |
| 707,000 | |
| 515,000 | |
| 51,140,000 | |
| 79,000 | |
| 326,000 | |
| 109,000 | |
| 4,000 | |
| 276,000 | |
| 200,000 | |
| 300,000 | |
| 24,740,000 | |
| 321,000 | |
| 1,671,000 | |
| 1,402,000 | |
| 3,719,000 | |
| 13,706,000 | |
| 3,769,000 | |
| 2,998,000 | |
| 3,046,000 | |
| 3,698,000 | |
| 3,066,000 | |
| 3,013,000 | |
| 1,157,000 | |
| 1,719,000 | |
| 939,000 | |
| 2,068,000 | |
| 1,645,000 | |
| 2,975,000 | |
| 3,750,000 | |
| 1,143,386 | |
| 1,420,000 | |
| 1,014,183 | |
| 1,190,723 | |
| 818,275 | |
| 1,115,209 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 252,608 | |
| 0 | |
| 0 | |
| 0 | |
| 134,848 | |
| 0 | |
| 0 | |
| 0 | |
| 4,846 | |
| 4,095 | |
| 10,054 | |
| 0 | |
| 4,909 | |
| 5,915 | |
| 4,287 | |
| 0 | |
| 7,916 | |
| 6,598 | |
| 505,511 | |
| 0 | |
| 255,953 | |
| 0 | |
| 0 | |
| 0 | |
| 5,800 | |
| 301,173 | |
| 0 | |
| 0 | |
| 0 | |
| 2,672 | |
| 510,579 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |